Clinical Trial of Solriamfetol for Excessive Sleepiness Related to Shift Work Disorder
Status:
Recruiting
Trial end date:
2023-10-01
Target enrollment:
Participant gender:
Summary
In this research study the investigators want to learn more about whether the medication
Solriamfetol improves daytime sleepiness in workers who start work at very early times
(between 3 and 6am).